The global demand for Helicobacter Pylori Diagnostics Market is presumed to reach the market size of nearly USD XX MN by 2030 from USD XX MN in 2022 with a CAGR of 7.4% under the study period 2023 - 2030.
Helicobacter pylori diagnostics refers to the methods and tests used to detect the presence of Helicobacter pylori (H. pylori) bacteria in the human body. It is a common bacterial infection that primarily affects the stomach and the upper part of the small intestine. It is a leading cause of various gastrointestinal diseases, including gastritis, peptic ulcers, and stomach cancer.
Market Dynamics
The high prevalence of H. pylori infection worldwide fuels the need for diagnostics to identify and manage the infection, particularly in regions with a higher incidence of related gastrointestinal diseases. As awareness of the risks associated with this infection, including gastritis, peptic ulcers, and stomach cancer, is growing, it is leading to the implementation of screening programs that drive the demand for diagnostic tests. Advancements in diagnostic technologies play a significant role in the market's growth. Improved non-invasive tests such as breath tests and stool antigen tests provide convenient and accurate methods of detecting H. pylori. Additionally, molecular techniques like PCR offer highly sensitive and specific results. The increasing demand for point-of-care testing for H. pylori diagnostics is also a driving factor, as it allows for immediate on-site testing, reducing the time required for diagnosis. The growth in the geriatric population, which is more susceptible to this infection and related gastrointestinal diseases, contributes to the demand for Helicobacter pylori diagnostics. Furthermore, the overall increase in healthcare expenditure and technological innovations in the field support the market's growth by making diagnostic tests more accessible and user-friendly.
The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of helicobacter pylori diagnostics. The growth and trends of helicobacter pylori diagnostics industry provide a holistic approach to this study.
Market Segmentation
This section of the helicobacter pylori diagnostics market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Technology
- Immunoassays
- POC
- Molecular Diagnostics
By End-User
- Hospitals
- Diagnostics Laboratories
- Clinics
Regional Analysis
This section covers the regional outlook, which accentuates current and future demand for the Helicobacter Pylori Diagnostics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
Global Helicobacter Pylori Diagnostics Market Share by Region (Representative Graph)

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the helicobacter pylori diagnostics market include Thermo Fisher Scientific, Bio-Rad Laboratories, Hoffmann-La Roche, Alpha Laboratories, Biohit, Meridian Bioscience, Quest Diagnostics, Coris BioConcept. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.